New Tools to Define Intervention in Asymptomatic Carotid Disease

This meta-analysis included 14 studies and compared the uptake of fluorodeoxyglucose (18F-FDG) according to positron emission tomography (PET)/computed tomography (CT) in symptomatic versus asymptomatic patients, demonstrating a significantly higher uptake in patients with symptomatic lesions. While PET/CT imaging of atheroma is a tool under investigation, with limited applicability in clinical practice, in a relatively close future, it might give insight into plaque biology so as to identify cases most likely to result in stroke. If so, it would become another tool to define intervention in patients who are asymptomatic but present highly inflamed and eventually unstable plaque.

This work included 539 symptomatic and asymptomatic patients who were assessed through PET/CT. Results were clear: patients with symptomatic lesions demonstrated a significantly higher tracer uptake (mean difference: 0.94; p < 0.0001).

 

Approximately 80% of strokes are ischemic in nature, and carotid lesions are deemed the source in 10% of cases. There is strong evidence that early intervention is key in reducing stroke rates in patients with significant symptomatic ipsilateral carotid disease. However, in asymptomatic patients, there are very few tools supporting intervention and most are in clear support of conservative management by best medical therapy available. Only a small proportion of asymptomatic patients with significant carotid artery lesions will develop a stroke or transient ischemic attack; having tools that will help to identify these patients might lead to interventions that will reduce the risk of future events. The use of 18F-FDG in PET/CT might be this new tool.

 

Conclusion

The use of 18F-FDG in PET/CT can demonstrate carotid plaque inflammation as a marker of symptomatic disease. Further studies are required to add these imaging techniques to clinical practice.

 

Original title: 18F-FDG Uptake on PET/CT in Symptomatic Versus Asymptomatic Carotid Disease: A Meta-Analysis.

Reference: Mohammed M. Chowdhury et al. Eur J Vasc Endovasc Surg (2018). Article in press.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

ACVC 2026 | FLASH Registry European Cohort: Mechanical Thrombectomy in Pulmonary Embolism

The management of intermediate-high and high-risk pulmonary embolism (PE) remains an area of therapeutic uncertainty, particularly in patients with right ventricular (RV) dysfunction, in...

AHA/ACC Guideline on the Management of Acute Pulmonary Embolism 2026

The 2026 ACC/AHA guideline for the management of acute pulmonary embolism (PE) introduces a conceptual shift by replacing the traditional “risk-based” classification with an...

FFR Assessment for the Selection of Hypertensive Patients Who Benefit from Renal Stenting

Atherosclerotic renal artery stenosis (ARAS) represents one of the main causes of secondary hypertension (HTN) and is associated with a higher risk of renal...

Transcatheter Deep Vein Arterialization in Critical Limb Ischemia Without Revascularization Options

Chronic limb-threatening ischemia in patients without conventional revascularization options represents one of the most challenging scenarios within peripheral arterial disease, with 1-year major amputation...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

ACVC 2026 | CELEBRATE Trial: Prehospital Zalunfiban Use in STEMI

Optimizing antithrombotic therapy in the prehospital phase of ST-segment elevation myocardial infarction (STEMI) remains challenging due to the delayed onset of action of P2Y12...

ACVC 2026 | BOX Substudy: Mean Arterial Pressure Targets in Cardiogenic Shock After OHCA

Hemodynamic management of cardiogenic shock following ischemic out-of-hospital cardiac arrest (OHCA-AMICS) remains an unresolved issue, particularly regarding optimal mean arterial pressure (MAP) targets and...

ACVC 2026 | FLASH Registry European Cohort: Mechanical Thrombectomy in Pulmonary Embolism

The management of intermediate-high and high-risk pulmonary embolism (PE) remains an area of therapeutic uncertainty, particularly in patients with right ventricular (RV) dysfunction, in...